Comprehensive Coronary Physiology in Patients With Angina With Nonobstructive Coronary Arteries - Czech Republic

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Motol

About this trial

Coronary artery disease (CAD) is a leading cause of morbidity and mortality. While cardiologists have been focused on discrete, visible stenoses of coronary arteries, there is increasing awareness of the importance of microcirculation and vasospastic disorders in causing angina. The microvascular bed is composed of vessels smaller than 400 microns in diameter. Their network is significantly larger than that of the epicardial vessels and serves essential functions, including regulating myocardial blood flow and cellular metabolism.

Angina pectoris, a most frequent symptom of CAD or myocardial ischemia, was assumed to be caused by significant stenosis of the epicardial coronary artery. However, it was found that in over 50% of cases, there was no obstructive CAD, which is described as angina with no obstructive coronary arteries (ANOCA) or ischemia with no obstructive coronary arteries (INOCA), according to the clinical setting.

Eligibility criteria

Qualifiers

Adults of both sexes older than 18 years

Angina symptoms or angina equivalent

Referred to cath lab for evaluation of CAD

Invasive physiology testing performed (microcirculation testing +/- vasospasm testing)

Disqualifiers

Persons under the age of 18

Pregnant of nursing

No coronary physiology measurements were performed

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

University Hospital, Motol

Lead sponsor

St. Anne's University Hospital Brno, Czech Republic

Collaborator

Nemocnice AGEL Trinec-Podlesi a.s.

Collaborator

Brno University Hospital

Collaborator

Institute for Clinical and Experimental Medicine

Collaborator